Related Experiment Videos
Prevalence, patterns, and correlates of voluntary flunitrazepam Use
V I Rickert1, C M Wiemann, A B Berenson
1Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555-0587, USA.
Pediatrics
|January 26, 1999
Summary
Voluntary flunitrazepam use is a growing health concern for young women. Risk factors include prior use of marijuana or LSD, peer influence, and a mother with a high school education.
Area of Science:
- Reproductive Health
- Substance Use Research
- Adolescent and Young Adult Health
Background:
- Voluntary flunitrazepam (Rohypnol) use presents emerging health risks.
- Understanding prevalence and patterns is crucial for targeted interventions.
Purpose of the Study:
- To determine the prevalence, patterns, and correlates of voluntary flunitrazepam use.
- Focus on sexually active adolescent and young adult women aged 14-26.
Main Methods:
- Cross-sectional survey conducted in university-based reproductive health clinics.
- 904 women (self-identified White, African-American, Mexican-American) participated.
- Assessed lifetime use, frequency, patterns, and physical effects of flunitrazepam.
Main Results:
- 5.9% of participants reported lifetime flunitrazepam use, with usage frequency varying widely.
- Flunitrazepam was frequently used with alcohol (74%) and other illicit drugs (49%).
- Users were more likely to report prior marijuana/LSD use, peer/partner flunitrazepam use, peer pressure, and maternal education.
Conclusions:
- Voluntary flunitrazepam use is a significant health concern for young women in the Southwestern US.
- Past use of LSD or marijuana and peer/partner use are key risk factors.
- 10% of users reported subsequent physical or sexual victimization.